PDC and prostate carcinoma: Recently, in prostate cancer, MAOA was reported to stabilize HIF-1α and mediate hypoxia by increasing ROS that can repress PHD activity, thereby enhancing the growth, invasion, and metastasis of prostate cancer cells 15.